Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Einstein

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2023
Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1Mark H Einstein, Richard B S Roden, Louise Ferrall, et al.
Cancer Biology & Therapy|September 24, 2010
Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6Rébécca Phaeton, Matthew Harris, Zewei Jiang, et al.
Plos One|October 12, 2012
Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptiveMarla J Keller, Colleen A Carpenter, Yungtai Lo, et al.
Gynecologic Oncology|September 19, 2006
Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists, Yvonne Collins, Mark H Einstein, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
Systematic Review of International Colposcopy Quality Improvement GuidelinesEdward J Mayeaux, Akiva P Novetsky, David Chelmow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Genetic variants in TAP are associated with high-grade cervical neoplasiaMark H Einstein, Suzanne Leanza, Lydia G Chiu, et al.
The Lancet. Infectious Diseases|May 27, 2009
Clinician's guide to human papillomavirus immunology: knowns and unknownsMark H Einstein, John T Schiller, Raphael P Viscidi, et al.
Gynecologic Oncology|October 16, 2007
Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcomaGloria S Huang, Lydia G Chiu, Juliana S Gebb, et al.
Oncotarget|August 25, 2016
A polycomb-mediated epigenetic field defect precedes invasive cervical carcinomaNeil Ari Wijetunga, Miriam Ben-Dayan, Jessica Tozour, et al.
International Journal of Molecular Sciences|June 10, 2022
Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine LeiomyosarcomaYasmin Abedin, Sofia Gabrilovich, Emily Alpert, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2023
Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1Mark H Einstein, Richard B S Roden, Louise Ferrall, et al.
Cancer Biology & Therapy|September 24, 2010
Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6Rébécca Phaeton, Matthew Harris, Zewei Jiang, et al.
Plos One|October 12, 2012
Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptiveMarla J Keller, Colleen A Carpenter, Yungtai Lo, et al.
Gynecologic Oncology|September 19, 2006
Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists, Yvonne Collins, Mark H Einstein, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
Systematic Review of International Colposcopy Quality Improvement GuidelinesEdward J Mayeaux, Akiva P Novetsky, David Chelmow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Genetic variants in TAP are associated with high-grade cervical neoplasiaMark H Einstein, Suzanne Leanza, Lydia G Chiu, et al.
The Lancet. Infectious Diseases|May 27, 2009
Clinician's guide to human papillomavirus immunology: knowns and unknownsMark H Einstein, John T Schiller, Raphael P Viscidi, et al.
Gynecologic Oncology|October 16, 2007
Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcomaGloria S Huang, Lydia G Chiu, Juliana S Gebb, et al.
Oncotarget|August 25, 2016
A polycomb-mediated epigenetic field defect precedes invasive cervical carcinomaNeil Ari Wijetunga, Miriam Ben-Dayan, Jessica Tozour, et al.
International Journal of Molecular Sciences|June 10, 2022
Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine LeiomyosarcomaYasmin Abedin, Sofia Gabrilovich, Emily Alpert, et al.
Pageof 14